#ACC20 – Randomized Trial: Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
30 Mar, 2020 | 01:03h | UTCSee also: Visual Abstract
Just Presented at the 2020 American College of Cardiology Virtual Meeting (free access)